Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Bcl-2, Bcl-x L, Mcl-1, and A1 are the predominant anti-apoptotic members of the Bcl-2 family in somatic cells. Malignant B lymphocytes are critically dependent on Bcl-2 or Bcl-x L for survival. In contrast, a new study by Glaser and colleagues in the January 15, 2012, issue of Genes & Development (pp. 120-125) demonstrates that Mcl-1 is essential for development and survival of acute myelogenous leukemia cells. These results provide new impetus for the generation of selective Mcl-1 inhibitors.

Original languageEnglish (US)
Pages (from-to)305-311
Number of pages7
JournalGenes and Development
Volume26
Issue number4
DOIs
StatePublished - Feb 15 2012

Fingerprint

Acute Myeloid Leukemia
Neoplasms
B-Lymphocytes
Genes

Keywords

  • Acute myeloid leukemia
  • Apoptosis
  • Bcl-x
  • Mcl-1

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors. / Gores, Gregory James; Kaufmann, Scott H.

In: Genes and Development, Vol. 26, No. 4, 15.02.2012, p. 305-311.

Research output: Contribution to journalArticle

@article{99b15dc73ab94540a4351b58ea4a8321,
title = "Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors",
abstract = "Bcl-2, Bcl-x L, Mcl-1, and A1 are the predominant anti-apoptotic members of the Bcl-2 family in somatic cells. Malignant B lymphocytes are critically dependent on Bcl-2 or Bcl-x L for survival. In contrast, a new study by Glaser and colleagues in the January 15, 2012, issue of Genes & Development (pp. 120-125) demonstrates that Mcl-1 is essential for development and survival of acute myelogenous leukemia cells. These results provide new impetus for the generation of selective Mcl-1 inhibitors.",
keywords = "Acute myeloid leukemia, Apoptosis, Bcl-x, Mcl-1",
author = "Gores, {Gregory James} and Kaufmann, {Scott H}",
year = "2012",
month = "2",
day = "15",
doi = "10.1101/gad.186189.111",
language = "English (US)",
volume = "26",
pages = "305--311",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "4",

}

TY - JOUR

T1 - Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors

AU - Gores, Gregory James

AU - Kaufmann, Scott H

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Bcl-2, Bcl-x L, Mcl-1, and A1 are the predominant anti-apoptotic members of the Bcl-2 family in somatic cells. Malignant B lymphocytes are critically dependent on Bcl-2 or Bcl-x L for survival. In contrast, a new study by Glaser and colleagues in the January 15, 2012, issue of Genes & Development (pp. 120-125) demonstrates that Mcl-1 is essential for development and survival of acute myelogenous leukemia cells. These results provide new impetus for the generation of selective Mcl-1 inhibitors.

AB - Bcl-2, Bcl-x L, Mcl-1, and A1 are the predominant anti-apoptotic members of the Bcl-2 family in somatic cells. Malignant B lymphocytes are critically dependent on Bcl-2 or Bcl-x L for survival. In contrast, a new study by Glaser and colleagues in the January 15, 2012, issue of Genes & Development (pp. 120-125) demonstrates that Mcl-1 is essential for development and survival of acute myelogenous leukemia cells. These results provide new impetus for the generation of selective Mcl-1 inhibitors.

KW - Acute myeloid leukemia

KW - Apoptosis

KW - Bcl-x

KW - Mcl-1

UR - http://www.scopus.com/inward/record.url?scp=84857168377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857168377&partnerID=8YFLogxK

U2 - 10.1101/gad.186189.111

DO - 10.1101/gad.186189.111

M3 - Article

C2 - 22345513

AN - SCOPUS:84857168377

VL - 26

SP - 305

EP - 311

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 4

ER -